Graham Peter Lidgard net worth and biography

Graham Lidgard Biography and Net Worth

Insider of Exact Sciences

Graham Lidgard is the co-inventor of Cologuard®, and has served as our Chief Science Officer since 2009. Prior to joining Exact Sciences, he served as Vice President, Research and Development at Nanogen, Inc., Vice President, Research and Development at Gen-Probe, Inc., and Co-founder and Vice President, Product Development at Matritech, Inc. Mr. Lidgard holds a bachelor’s degree with honors as well as a doctoral degree from the University of Manchester.

What is Graham Peter Lidgard's net worth?: The estimated net worth of Graham Peter Lidgard is at least $2.10 million as of March 2nd, 2021. Mr. Lidgard owns 48,014 shares of Exact Sciences stock worth more than $2,096,291 as of March 30th. This net worth evaluation does not reflect any other assets that Mr. Lidgard may own. Learn More about Graham Peter Lidgard's net worth.
How do I contact Graham Peter Lidgard?: The corporate mailing address for Mr. Lidgard and other Exact Sciences executives is 5505 ENDEAVOR LANE, MADISON WI, 53719. Exact Sciences can also be reached via phone at (608) 284-5700 and via email at meganjones@exactsciences.com. Learn More on Graham Peter Lidgard's contact information.
Has Graham Peter Lidgard been buying or selling shares of Exact Sciences?: Graham Peter Lidgard has not been actively trading shares of Exact Sciences during the past quarter. Most recently, Graham Peter Lidgard sold 11,735 shares of the business's stock in a transaction on Friday, March 5th. The shares were sold at an average price of $121.33, for a transaction totalling $1,423,807.55. Learn More on Graham Peter Lidgard's trading history.
Who are Exact Sciences' active insiders?: Exact Sciences' insider roster includes Brian Baranick (Insider), Sarah Condella (SVP), Kevin Conroy (CEO), D. Coward (Insider), Everett Cunningham (Insider), James Doyle (Director), Jeffrey Elliott (CFO), James Herriott (General Counsel), Torsten Hoof (Insider), Daniel Levangie (Director), Graham Lidgard (Insider), Jacob Orville (Insider), and Katherine Zanotti (Director). Learn More on Exact Sciences' active insiders.
Are insiders buying or selling shares of Exact Sciences?: In the last twelve months, Exact Sciences insiders bought shares 1 times. They purchased a total of 19,500 shares worth more than $1,001,325.00. In the last twelve months, insiders at the medical research company sold shares 8 times. They sold a total of 5,356 shares worth more than $360,164.70. The most recent insider tranaction occured on November, 13th when CEO Kevin T Conroy bought 19,500 shares worth more than $1,001,325.00. Insiders at Exact Sciences own 1.4% of the company. Learn More about insider trades at Exact Sciences.
Information on this page was last updated on 11/13/2024.

Graham Peter Lidgard Insider Trading History at Exact Sciences

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/5/2021	Sell	11,735	$121.33	$1,423,807.55
3/2/2021	Sell	2,524	$138.42	$349,372.08	48,014
2/24/2021	Sell	5,842	$136.30	$796,264.60	47,171
11/7/2018	Sell	38,311	$75.01	$2,873,708.11	29,398
11/5/2018	Sell	37,613	$75.01	$2,821,351.13	29,398
11/1/2018	Sell	79,673	$71.73	$5,714,944.29	124,528
10/8/2018	Sell	58,000	$69.36	$4,022,880.00	204,684
3/9/2018	Sell	6,125	$50.94	$312,007.50	200,074
2/28/2018	Sell	39,884	$43.10	$1,719,000.40
12/1/2017	Sell	45,770	$58.27	$2,667,017.90	237,820
11/1/2017	Sell	45,775	$53.60	$2,453,540.00	272,819
10/2/2017	Sell	81,025	$47.16	$3,821,139.00	366,519
9/5/2017	Sell	75,683	$40.81	$3,088,623.23	308,377
9/1/2017	Sell	45,775	$41.49	$1,899,204.75	288,952
2/27/2017	Sell	8,668	$21.51	$186,448.68	314,527
7/26/2016	Sell	7,383	$14.82	$109,416.06	227,592
3/10/2016	Sell	3,041	$6.05	$18,398.05	228,170
2/25/2016	Sell	2,997	$5.52	$16,543.44	222,742
2/23/2016	Sell	2,411	$6.39	$15,406.29	216,903
2/26/2015	Sell	3,938	$23.44	$92,306.72
2/24/2015	Sell	4,037	$22.90	$92,447.30
1/2/2015	Sell	3,363	$26.72	$89,859.36
10/29/2014	Sell	8,015	$24.68	$197,810.20
7/25/2014	Sell	11,081	$15.99	$177,185.19
2/24/2014	Sell	3,160	$14.07	$44,461.20	106,214
1/2/2014	Sell	10,288	$11.96	$123,044.48	102,149
10/28/2013	Sell	7,430	$11.07	$82,250.10

See Full Table

Graham Peter Lidgard Buying and Selling Activity at Exact Sciences

Exact Sciences Company Overview

Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX Breast Recurrence Score Test; Oncotype DX Breast DCIS Score Test; Oncotype DX Colon Recurrence Score Test; OncoExTra Test for tumor profiling for patients with advanced, metastatic, refractory, relapsed, or recurrent cancer; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research, and Johns Hopkins University. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.

Today's Range

Now: $43.66

$43.55

$44.98

50 Day Range

MA: $49.71

$43.04

$56.05

2 Week Range

Now: $43.66

$40.62

$79.62

Volume

1,336,419 shs

Average Volume

2,626,482 shs

Market Capitalization

$8.11 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.25